Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Lifecore Biomedical ( (LFCR) ) has shared an announcement.
Lifecore Biomedical, Inc. is set to undergo changes in its Board of Directors as Jeffrey L. Edwards has chosen not to seek re-election and Ray Diradoorian plans to resign, both occurring around the company’s 2024 Annual Meeting scheduled for November 7. These decisions are not due to any operational disagreements. Shareholders interested in submitting proposals or nominations now face an October 3 deadline, following the regulatory and company bylaw requirements. These changes and submission details are crucial for investors as they could influence the company’s direction and governance.
See more insights into LFCR stock on TipRanks’ Stock Analysis page.
